Witryna5 gru 2013 · Syner-G Acquires IMPACT, Expands Services for Biotech and Pharma Companies - IMPACT Pharmaceutical... Boston, MA (February 1, 2024) – Syner-G BioPharma Group (“Syner-G” or the … WitrynaOur investment is in People who make an impact, drive progress and create a better tomorrow. Our strategy includes building teams across our global network to pioneer and shape the future of PCI. We now have an exciting opportunity for a Project Manager to join our team at PCI Pharma Services in Tredegar, Wales, UK. This is a maternity …
Tim Garver - Chief Scientific Officer and Chief Compliance
WitrynaLife changing therapies. Global impact. Bridge to thousands of biopharma companies and their patients. We are PCI. Our investment is in People who make an impact, drive progress and create a better tomorrow. Our strategy includes building teams across our global network to pioneer and shape the future of PCI. WitrynaImpact Health offers a wide range of services to the pharmaceutical industry and healthcare sector globally. Since 2007, we have been licensed suppliers of … risk of harm hearing
Top 10 Pharma Industry Trends in 2024 StartUs Insights
WitrynaImpact Pharmaceutical Services, Inc. Aug 2009 - Present 13 years 9 months. Research Triangle Park, NC Senior Director, Regulatory … WitrynaImpact Pharmaceutical Services 2182 obserwujących na LinkedIn. IMPACT is a Contract Research Organization (CRO) in Research Triangle Park, NC that specializes in the following services: • Medical writing and quality control • Drug development consulting • Regulatory affairs • Regulatory operations • Project and program … WitrynaWith our acquisition of Impact Pharmaceutical Services in early 2024, we provide the complete suite of regulatory affairs services including regulatory strategy, publishing, … In 2024, Syner-G acquired Impact Pharmaceutical Services. Based in … The Team - Syner-G BioPharma Group Syner-G Biopharma Group acquires Impact; expands services for biotech and … Contact - Syner-G BioPharma Group December 14, 2024 Kathryn Tworkoski, PhD, RAC, Senior Clinical Research … Development of Complex Biologics as Therapeutic Modalities. Syner-G … Phase-Appropriate, Science- and Risk-Based Approach to Quality and … For customers looking for offshore resources, Syner-G also offers CMC … smh manufacturing